Финска - Фински - Fimea (Suomen lääkevirasto)

krka sverige ab - galantamine hydrobromide - depotkapseli, kova - 24 mg - galantamiini

Финска - Фински - Fimea (Suomen lääkevirasto)

orion corporation - galantamine hydrobromide - depotkapseli, kova - 8 mg - galantamiini

Финска - Фински - Fimea (Suomen lääkevirasto)

orion corporation - galantamine hydrobromide - depotkapseli, kova - 16 mg - galantamiini

Финска - Фински - Fimea (Suomen lääkevirasto)

orion corporation - galantamine hydrobromide - depotkapseli, kova - 24 mg - galantamiini

Финска - Фински - Fimea (Suomen lääkevirasto)

stada arzneimittel ag - galantamine hydrobromide - depotkapseli, kova - 8 mg - galantamiini

Финска - Фински - Fimea (Suomen lääkevirasto)

stada arzneimittel ag - galantamine hydrobromide - depotkapseli, kova - 16 mg - galantamiini

Финска - Фински - Fimea (Suomen lääkevirasto)

stada arzneimittel ag - galantamine hydrobromide - depotkapseli, kova - 24 mg - galantamiini

Европска Унија - Фински - EMA (European Medicines Agency)

adienne s.r.l. s.u. - melphalan hydrochloride - multiple myeloma; hodgkin disease; lymphoma, non-hodgkin; precursor cell lymphoblastic leukemia-lymphoma; leukemia, myeloid, acute; neuroblastoma; ovarian neoplasms; hematopoietic stem cell transplantation - antineoplastiset aineet - high-dose of phelinun used alone or in combination with other cytotoxic medicinal products and/or total body irradiation is indicated in the treatment of:multiple myeloma,malignant lymphoma (hodgkin, non-hodgkin lymphoma),acute lymphoblastic and myeloblastic leukemia,childhood neuroblastoma,ovarian cancer,mammary adenocarcinoma. phelinun in combination with other cytotoxic medicinal products is indicated as reduced intensity conditioning (ric) treatment prior to allogeneic haematopoietic stem cell transplantation (allo-hsct) in malignant haematological diseases in adults. phelinun in combination with other cytotoxic medicinal products is indicated as conditioning regimen prior to allogeneic haematopoietic stem cell transplantation in haematological diseases in the paediatric population as:myeloablative conditioning (mac) treatment in case of malignant haematological diseasesric treatment in case of non-malignant haematological diseases.

Финска - Фински - Fimea (Suomen lääkevirasto)

medical valley invest ab - losartan potassium - tabletti, kalvopäällysteinen - 12.5 mg - losartaani

Финска - Фински - Fimea (Suomen lääkevirasto)

medical valley invest ab - losartan potassium - tabletti, kalvopäällysteinen - 50 mg - losartaani